Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
10,061,469
-
Share change
-
-4,334,596
-
Total reported value
-
$14,999,000
-
Price per share
-
$1.50
-
Number of holders
-
16
-
Value change
-
-$12,301,893
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of SOLENO THERAPEUTICS INC - COM NEW (SLNO) as of Q3 2019
As of 30 Sep 2019,
SOLENO THERAPEUTICS INC - COM NEW (SLNO) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,061,469 shares.
The largest 10 holders included
Abingworth LLP, ORACLE INVESTMENT MANAGEMENT INC, 683 Capital Management, LLC, Trellus Management Company, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and SHIKIAR ASSET MANAGEMENT INC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.